Bioheart (02185 HK) announces clinical result for Iberis-HTN at CIT 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shanghai Bio-heart Biological Technology Co , Ltd: Bioheart (02185 HK) announces clinical result for Iberis-HTN at CIT 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Treatment Supported by Evidence from Multiple Studies and Renal Denervation Position Paper from the European Society of Hypertension ReCor Medical, Inc. ("ReCor"), a wholly owned subsidiary of Otsuka